Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase
about
Kidney xenotransplantationImmune modulation in xenotransplantationXenotransplantation: where are we today?Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells.Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells.Chimerism and xenotransplantation. New concepts.The major histocompatibility complex in swine.Prospects for xenotransplantation.Potential use of genetically modified pigs as organ donors for transplantation into humans.Current status of xenotransplantation.Induction of human blood group a antigen expression on mouse cells, using lentiviral gene transduction.Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species.Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs.Characterizing and mapping porcine endogenous retroviruses in Westran pigs.The future promises of xenotransplantation.The pig as a source of cardiac xenografts.Therapeutic strategies for xenograft rejection.Genetic therapies and xenotransplantation.Reducing Gal expression on the pig organ - a retrospective review.Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejectionLessons learned from mouse models of hemolytic transfusion reactionsWill xenotransplantation ever be feasible?Genetically modified pigs for biomedical research.Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.Adenovirus-mediated expression of pig alpha(1, 3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells.Expression of alpha-1,3-galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha-1,2-fucosyltransferase cDNA.Interspecies chimeric complementation for the generation of functional human tissues and organs in large animal hosts.Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology.Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig.Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc.Generation and testing of a highly specific anti-serum directed against porcine endogenous retrovirus nucleocapsid.Xenoantigens and xenoantibodies.Neonatal porcine pancreatic cell clusters as a potential source for transplantation in humans: characterization of proliferation, apoptosis, xenoantigen expression and gene delivery with recombinant AAV.Directing flux in glycan biosynthetic pathways with a small molecule switch.The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells.Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research.Analysis of swine leukocyte antigen class I gene profiles and porcine endogenous retrovirus viremia level in a transgenic porcine herd inbred for xenotransplantation research.Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
P2860
Q26822638-CF9C89B9-B87B-495B-A1A5-8764743C32DEQ26826905-EC0FDBBA-A84F-41DD-979D-D25B85517EA8Q28972293-BFD45BBE-6C73-43CA-AB03-7007B2C12CF9Q30668720-8D9FC96A-0ECB-4A60-90DB-417AB9352254Q30855704-48253BDE-08EB-4243-A9E1-B1EE256DCBD7Q33540226-12D7EAE7-0CFA-4FA1-A27D-47ACE2295DA7Q33630668-CD7F0276-C6C9-456A-8D71-3F9E533024A8Q33732951-EACD0B20-65C2-47BC-A740-B4C536C8F06BQ33811447-6B127791-CDF6-4291-88ED-4A89C9D7C7FEQ33811452-42E0FE79-7213-4946-AB40-496A6D86063AQ34123280-A2A793EE-6118-44D4-B08A-84F6DC007941Q34232667-AAB3E185-FC18-4414-849D-AC22C020EA0FQ34352999-18D12E5F-552B-446B-9F48-9135170562FCQ34364467-CB40B2ED-FC7C-49F3-A223-AF130A750791Q34490476-966AAC3D-F1AD-435C-970D-6ED15A4AA100Q34556099-A113CD1E-36AD-4A0C-B0FD-AB92BC4FA10BQ34556105-E7739ADC-F9CD-47A9-B665-A7F8C3F2212DQ34560676-30CCF7FF-4F15-4580-9EF9-0DDEB0D50813Q36155941-304E5B85-8144-4F65-B521-6F446B38E35DQ36400683-4B99E03A-9173-4BC9-B2B0-CFBB4A942C9EQ37039345-5A65C992-E4B8-49AD-B211-EA36BEDEAFABQ37106223-F59B4397-93B0-47C2-95CD-508379EE94E0Q37347546-F850BAE8-4586-4B3E-8881-65D1DF18728FQ37997627-CC77A9A6-3542-4EC2-B2A3-F6E541F67D26Q38289368-20E226DA-D3DD-4655-B63F-F9337E2C25C2Q38299022-5AF96C2C-0818-4AE0-A5F6-2F2EA79BB175Q38343160-76C0A84C-0C5A-4CCD-B332-FB9E95A8DE21Q38714826-5FD690C3-B8BF-443A-8030-EBCEA151EB55Q39523461-8CFD3799-0927-4931-8453-50699340D1D5Q40655584-3085FEF5-9BBB-4725-BC9A-219302782B15Q40693500-C000E7C0-5A64-4A36-9D40-6156FEF00B6BQ40793967-9F59137B-DAEC-4423-BC48-29BCEBA9DB4FQ40850917-2A922C5E-911F-4DBB-95DB-AEBE7BC110EBQ41723362-2BB51DBF-617E-41B3-8B43-A2F10114F5A0Q43989250-A9E7D636-0ADA-48B5-89A1-CFF1F577BDDEQ45085397-CAEEB470-D2EA-42FD-8AD0-F868E8696FFEQ45878843-8F2497CE-5956-4C9E-82B4-A73E7D13F3B1Q46606726-90163B04-C4E8-4900-93F7-B778CA227B41Q47549260-54E94F75-A3C0-4817-B2FB-91A06A31514BQ47712226-CC2A811C-7D86-410C-903B-A84A6FFF9BC9
P2860
Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@ast
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@en
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@nl
type
label
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@ast
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@en
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@nl
prefLabel
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@ast
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@en
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@nl
P2093
P2860
P356
P1476
Reduction in the level of Gal( ...... n alpha(1,2)fucosyltransferase
@en
P2093
M J Martin
S B McClellan
P2860
P304
P356
10.1073/PNAS.93.14.7190
P407
P577
1996-07-01T00:00:00Z